# A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery

> **NCT00594464** · PHASE4 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 14 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Rotigotine

## Key facts

- **NCT ID:** NCT00594464
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2014-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00594464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00594464, "A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00594464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*